Tirzepatide, Retatrutide, and Semaglutide are the three most-studied GLP-1 receptor agonists in preclinical research, and they differ primarily in how many receptors each one targets. Semaglutide acts on a single receptor (GLP-1), Tirzepatide acts on two (GIP + GLP-1), and Retatrutide acts on three (GIP + GLP-1 + glucagon). That receptor-count difference is the single biggest factor driving how researchers choose between them.
If you are sourcing these peptides for a lab, the practical questions are not about “which is better” but about purity, batch documentation, and which receptor profile actually matches your study design. I have ordered GLP-1 peptides from several suppliers, and the same rule applies every time: the COA matters more than the brand name.
Receptor Targets — The Core Difference
The mechanism difference is simple to summarize: more receptors targeted means a broader metabolic profile, but also a more complex data readout.
- Semaglutide — GLP-1 receptor agonist only. The most narrowly targeted of the three.
- Tirzepatide — dual GIP/GLP-1 receptor agonist. Adds incretin activity on top of GLP-1.
- Retatrutide — triple GIP/GLP-1/glucagon agonist. The broadest receptor coverage.
For a researcher, a dual or triple agonist generates more variables to control for. A single-agonist study is cleaner to interpret, which is why Semaglutide remains the most common baseline in comparative literature.
Purity and Molecular Verification
All three peptides should come with a third-party HPLC report showing ≥98% purity, plus a mass spectrometry readout that confirms the expected molecular weight. This is non-negotiable for research-grade material.
- HPLC — confirms purity percentage and flags impurities.
- Mass Spectrometry (MS) — confirms the molecular weight matches the sequence.
- Peptide content — lyophilized vials should state net peptide weight, not just total fill weight.
| Attribute | Semaglutide | Tirzepatide | Retatrutide |
|---|---|---|---|
| Receptor targets | GLP-1 | GIP + GLP-1 | GIP + GLP-1 + Glucagon |
| Class | GLP-1 agonist | Dual incretin agonist | Triple agonist |
| Research focus | Single-pathway studies | Dual-pathway metabolic studies | Broad metabolic studies |
| Required documentation | HPLC + MS | HPLC + MS | HPLC + MS |
How to Compare Suppliers Before Ordering
The fastest way to filter suppliers is to ask for a batch-specific COA up front, and to verify that the testing lab is independent from the seller. If a supplier cannot produce both HPLC and mass spec data for the exact batch they are shipping, move on.
Also confirm storage and packaging: lyophilized vials should be vacuum-sealed, ideally under inert gas, and shipped cold where the route requires it. For bulk orders, ask about the minimum order quantity (MOQ) and whether sample vials are available for initial testing.
FAQ
What is the actual difference between Tirzepatide and Retatrutide?
Retatrutide adds a glucagon receptor target that Tirzepatide does not have, making it a triple agonist versus Tirzepatide’s dual agonist. This broadens the metabolic pathways affected, which changes the research readout and the complexity of the study design.
Is Semaglutide still relevant for research now that triple agonists exist?
Yes — Semaglutide remains the cleanest single-receptor baseline for comparative studies precisely because it is the least complex. Researchers who want to isolate GLP-1 effects still reach for it first.
What purity should I require when buying these peptides wholesale?
Require ≥98% purity by HPLC with a matching mass spectrometry report for every batch. Accepting anything lower, or a COA that is not batch-specific, is the most common way labs waste money on unusable material.
Which of the three is most commonly stocked by EU-based suppliers?
All three are widely stocked, but Semaglutide and Tirzepatide generally have faster turnaround because they are the highest-volume items. Retatrutide is newer and may have longer lead times on large custom orders.
Contact Our Research Team
For batch-specific COA documents, bulk pricing, or current stock availability, reach us on WhatsApp (+852 4419 8097) or browse the full catalog at tb500.pro.
Important: All products are sold strictly for laboratory and research purposes only — not for human or veterinary use. No medical or dosing guidance is provided.